Kuşku Cabuk Fatmagül, Yığıt Seyran, Demır Lütfiye, Cakalağaoğlu Fulya, Tarhan Oktay
Department of Pathology, İzmir Aliağa State Hospital, İZMİR, TURKEY.
Turk Patoloji Derg. 2014;30(1):30-7. doi: 10.5146/tjpath.2013.01203.
Pathological stage is the most important prognostic factor in ovarian carcinomas, and many studies have been carried out to predict prognosis. In our study, we searched the expression of survivin, which prevents apoptosis and matrix metalloproteinase-9 (MMP-9), which promotes the metastasis of the tumour by splitting up the basal membrane in primary epithelial ovarian carcinomas. We aimed to observe their effects on prognosis by comparing clinicopathological parameters.
60 cases diagnosed with epithelial ovarian carcinoma between 2003 and 2008 and treated and followed up at the oncology clinic were included in the study. 42 patients were serous, 11 endometrioid, 5 mixed type, 1 was clear cell and 1 was undifferentiated adenocarcinoma. Survivin and MMP-9 expression was evaluated in each tumour and assosication with clinicopathological parameters (age, tumour diameter, localisation, histological type of tumour, grade, stage, recurrence and metastasis) were searched and also overall survival and disease free of survival were evaluated.
Survivin was statistically insignificant within the clinicopathological parameters. The correlation between the tumour grade and the staining density of MMP-9 in epithelial cells (p=0.028) and the correlation between disease free of survival and MMP-9 expression in stromal cells (p=0.0326) was significant. When the stage was compered with clinocopathologic parameters; recurrence (p=0.005) and death rates (p < 0.001) were significantly increased but overall survival (p=0.0269) was significantly decreased in advanced-stage patients.
In the present study, the stage was found to be an important prognostic parameter in surface epithelial ovarian carcinomas and an association was found between MMP-9 stromal staining and survival.
病理分期是卵巢癌最重要的预后因素,已经开展了许多研究来预测预后。在我们的研究中,我们检测了生存素的表达,其可阻止细胞凋亡,还检测了基质金属蛋白酶-9(MMP-9)的表达,其通过分解原发性上皮性卵巢癌的基底膜促进肿瘤转移。我们旨在通过比较临床病理参数来观察它们对预后的影响。
本研究纳入了2003年至2008年间在肿瘤门诊诊断为上皮性卵巢癌并接受治疗和随访的60例患者。42例为浆液性癌,11例为子宫内膜样癌,5例为混合型,1例为透明细胞癌,1例为未分化腺癌。评估每个肿瘤中生存素和MMP-9的表达,并研究其与临床病理参数(年龄、肿瘤直径、定位、肿瘤组织学类型、分级、分期、复发和转移)的相关性,同时评估总生存期和无病生存期。
生存素在临床病理参数中无统计学意义。上皮细胞中肿瘤分级与MMP-9染色密度之间的相关性(p = 0.028)以及基质细胞中无病生存期与MMP-9表达之间的相关性(p = 0.0326)具有显著性。当将分期与临床病理参数进行比较时;晚期患者的复发率(p = 0.005)和死亡率(p < 0.001)显著增加,但总生存期(p = 0.0269)显著降低。
在本研究中,分期被发现是表面上皮性卵巢癌的一个重要预后参数,并且发现MMP-9基质染色与生存之间存在关联。